1. Home
  2. Labeler Index
  3. Medical Purchasing Solutions, Llc
  4. 71872-7168
  5. NDC Package Code: 71872-7168-1 Clindamycin

NDC Package 71872-7168-1 Clindamycin

Injection, Solution Intramuscular; Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71872-7168-1
Package Description:
1 VIAL, SINGLE-DOSE in 1 BAG / 4 mL in 1 VIAL, SINGLE-DOSE
Product Code:
71872-7168
Proprietary Name:
Clindamycin
Non-Proprietary Name:
Clindamycin
Substance Name:
Clindamycin
Usage Information:
Clindamycin Injection, USP is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.Clindamycin Injection, USP products are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of antibiotic-associated pseudomembranous colitis, as described in the BOXED WARNING, before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). Bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin.Indicated surgical procedures should be performed in conjunction with antibiotic therapy.Clindamycin Injection, USP is indicated in the treatment of serious infections caused by susceptible strains of the designated organisms in the conditions listed below:Lower respiratory tract infections including pneumonia, empyema, and lung abscess caused by anaerobes, Streptococcus pneumoniae, other streptococci (except E. faecalis), and Staphylococcus aureus.Skin and skin structure infections caused by Streptococcus pyogenes, Staphylococcus aureus, and anaerobes. Gynecological infections including endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection caused by susceptible anaerobes.Intra-abdominal infections including peritonitis and intra-abdominal abscess caused by susceptible anaerobic organisms.Septicemia caused by Staphylococcus aureus, streptococci (except Enterococcus faecalis), and susceptible anaerobes. Bone and joint infections including acute hematogenous osteomyelitis caused by Staphylococcus aureus and as adjunctive therapy in the surgical treatment of chronic bone and joint infections due to susceptible organisms. To reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin injection, USP and other antibacterial drugs, clindamycin injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
11-Digit NDC Billing Format:
71872716801
NDC to RxNorm Crosswalk:
  • RxCUI: 1737578 - clindamycin 600 MG in 4 ML Injection
  • RxCUI: 1737578 - 4 ML clindamycin 150 MG/ML Injection
  • RxCUI: 1737578 - clindamycin (as clindamycin phosphate) 600 MG per 4 ML Injection
  • RxCUI: 1737578 - clindamycin 600 MG per 4 ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Medical Purchasing Solutions, Llc
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • CLINDAMYCIN 150 mg/mL
    • Pharmacologic Class(es):
  • Decreased Sebaceous Gland Activity - [PE] (Physiologic Effect)
  • Lincosamide Antibacterial - [EPC] (Established Pharmacologic Class)
  • Lincosamides - [CS]
  • Neuromuscular Blockade - [PE] (Physiologic Effect)
    • Sample Package:
    No
    FDA Application Number:
    ANDA204748
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    11-29-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 71872-7168-1?

    The NDC Packaged Code 71872-7168-1 is assigned to a package of 1 vial, single-dose in 1 bag / 4 ml in 1 vial, single-dose of Clindamycin, a human prescription drug labeled by Medical Purchasing Solutions, Llc. The product's dosage form is injection, solution and is administered via intramuscular; intravenous form.

    Is NDC 71872-7168 included in the NDC Directory?

    Yes, Clindamycin with product code 71872-7168 is active and included in the NDC Directory. The product was first marketed by Medical Purchasing Solutions, Llc on November 29, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 71872-7168-1?

    The 11-digit format is 71872716801. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-171872-7168-15-4-271872-7168-01